Italy Allergy Diagnostics Market (2026-2031)
The Italy Allergy Diagnostics Market was valued at $138.9 Million in 2026 and projected to reach to $221.5 Million by 2031, representing a compound annual growth rate of 9.8%. Italy's allergy diagnostics market is positioned for sustained expansion through 2031, driven by demographic shifts, lifestyle factors, and environmental triggers increasing allergic disease incidence.
Italy Allergy Diagnostics Market Trends and Insights
- This expansion reflects Italy's increasing prevalence of allergic diseases and rising healthcare investment in diagnostic infrastructure.
- Italy's market growth rate of 9.8% CAGR outpaces several European peers, driven by heightened awareness of allergy testing and improved access to advanced diagnostic technologies across Italian healthcare systems. The Italian market benefits from a well-established healthcare framework and growing demand for personalized medicine approaches.
- Italy's aging population and environmental factors contribute to sustained allergy incidence, creating consistent demand for diagnostic solutions.
- Between 2026 and 2031, Italy is expected to see significant adoption of molecular and component-resolved diagnostics, positioning the country as a key growth market within the European allergy diagnostics landscape..
Key Market Statistics
- CAGR (2026-2031) 9.8% CAGR
- Market Size, 2026 ~USD 138.9 Million
- Forecast, 2031 ~USD 221.5 Million
- Country Italy
Italy Allergy Diagnostics Market Overview
Market Valuation Growth :
Italy's allergy diagnostics market is valued at USD 138.9 million in 2026 and is projected to reach USD 221.5 million by 2031, representing a robust 59.4% absolute growth over the forecast period.
Outpacing European Growth :
Italy's market CAGR of 9.8% exceeds the global average of 9.6%, positioning the country as a high-growth market within Europe and reflecting stronger adoption of advanced diagnostic solutions.
Rising Allergy Prevalence :
Increasing prevalence of allergic diseases across Italy's population is driving demand for accurate and timely diagnostic testing, supported by heightened public awareness and healthcare provider education initiatives.
Healthcare Infrastructure Investment :
Italy's commitment to modernizing diagnostic infrastructure and expanding laboratory capabilities is accelerating the adoption of innovative allergy testing technologies and methodologies.
Italy Allergy Diagnostics Market Dynamics
- Healthcare providers are increasingly investing in advanced diagnostic platforms to improve patient outcomes and reduce misdiagnosis rates.
- The Italian government's focus on preventive healthcare and diagnostic accuracy is creating favorable conditions for market growth. Key growth catalysts include rising healthcare spending, growing patient awareness of allergy testing benefits, and the adoption of molecular and component-resolved diagnostics.
- Regional healthcare systems are prioritizing allergy management protocols, creating opportunities for diagnostic service providers and equipment manufacturers to expand their market presence across Italy's major metropolitan and secondary healthcare centers..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Italy's allergy diagnostics market is valued at USD 138.9 million in 2026 and will reach USD 221.5 million by 2031, representing a 9.8% CAGR.
- Italy's market growth rate exceeds the global average, reflecting strong regional demand and healthcare system modernization.
- Advanced diagnostic technologies and component-resolved testing are driving adoption across Italian clinical settings.
- Italy's established healthcare infrastructure and aging population support sustained long-term market expansion through 2031.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
Italy Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Equipment Manufacturers : Need Italy-specific market sizing and growth forecasts to plan product launches, allocate R&D resources, and establish distribution partnerships in this expanding European diagnostic market.
- Healthcare Investment Firms : Require detailed Italy market analysis to evaluate investment opportunities in diagnostic companies, laboratory networks, and healthcare technology providers operating in the allergy diagnostics sector.
- Clinical Laboratory Operators : Seek market intelligence on Italy's allergy testing demand, competitive landscape, and service expansion opportunities to optimize laboratory capacity planning and service portfolio development.
- Healthcare Consultants & Advisors : Need Italy-focused market data and trend analysis to advise healthcare systems, diagnostic providers, and pharmaceutical companies on market opportunities and strategic positioning in allergy diagnostics.
- Pharmaceutical & Biotech Companies : Require Italy market insights to inform companion diagnostic development, clinical trial planning, and commercial strategies for allergy-related therapeutics and diagnostic solutions.
Key Companies in the Italy Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market-Specific Growth Projections : Access precise Italy-focused valuation data (USD 138.9M in 2026 to USD 221.5M in 2031) with detailed CAGR analysis to inform investment and expansion strategies in this high-growth European market.
- Competitive Positioning Intelligence : Understand Italy's 9.8% CAGR advantage over global benchmarks to identify competitive opportunities and market gaps where diagnostic providers can differentiate and capture market share.
- Localized Demand Drivers : Gain insights into Italy-specific factors driving allergy diagnostics adoption, including prevalence trends, healthcare infrastructure investments, and regional regulatory environments affecting market dynamics.
- Strategic Market Entry Planning : Leverage Italy-specific market data to develop targeted go-to-market strategies, identify key healthcare stakeholders, and prioritize geographic regions within Italy with highest growth potential.
- Investment Decision Support : Make informed capital allocation decisions with comprehensive Italy market analysis, including growth trajectory validation, risk assessment, and ROI projections for diagnostic technology and service investments.
Frequently asked questions
What is the current size of Italy's allergy diagnostics market?
Italy's allergy diagnostics market is valued at USD 138.9 million in 2026 and is projected to grow to USD 221.5 million by 2031.
What is the expected growth rate for Italy's allergy diagnostics market?
Italy's allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2031.
What factors are driving growth in Italy's allergy diagnostics market?
Growth in Italy is driven by increasing allergy prevalence, rising healthcare investment, growing awareness of diagnostic testing, and adoption of advanced molecular and component-resolved diagnostic technologies.
How does Italy's market growth compare to global trends?
Italy's 9.8% CAGR exceeds the global allergy diagnostics market CAGR of 9.6%, positioning Italy as a faster-growing regional market.
What diagnostic technologies are gaining traction in Italy?
Molecular diagnostics, component-resolved diagnostics, and advanced immunoassay platforms are increasingly adopted across Italian healthcare facilities and private diagnostic centers.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report